Dr. Jonathan Berg, MD

• Genetics

• Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of North Carolina At Chapel Hill

  Medical School, 2003

• Lumping versus splitting: How to approach defining a disease to enable accurate genomic curation, 2022-05-11

• Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making, 2021-03-29

• Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings, 2018-09-21

• Genomic Knowledge in the Context of Diagnostic Exome Sequencing: Changes over Time, Persistent Subgroup Differences, and Associations with Psychological Sequencing Outcomes, 2019-07-17

• Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice, 2015-08-25

• Increasing the diagnostic yield of exome sequencing by copy number variant analysis, 2018-12-17

• We screen newborns, don't we?: realizing the promise of public health genomics, 2013-03-07

• The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources, 2022-05-04

• Characterizing Genetic Variants for Clinical Action, 2014-03-13

• The Promise and Peril of Genomic Screening in the General Population, 2015-11-05

• Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete choice experiment, 2017-08-03

• Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol, 2018-06-28

• Description and Pilot Results from a Novel Method for Evaluating Return of Incidental Findings from Next Generation Sequencing Technologies, 2013-04-04

• US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER), 2021-11-30

• A Behavior-Theoretic Evaluation of Values Clarification on Parental Beliefs and Intentions Toward Genomic Sequencing for Newborns, 2018-11-09

• ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation., 2018-09-06

• The Phenotype of Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 1: Report and Review, 2015-04-29

• Identifying Gene Disruptions in Novel Balancedde novoConstitutional Translocations in Childhood Cancer Patients by Whole Genome Sequencing, 2015-01-08

• Prenatal Exome Sequencing in Anomalous Fetuses: New Opportunities and Challenges, 2017-05-18

• An approach to integrating exome sequencing for fetal structural anomalies into clinical practice, 2020-01-24

• Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience, 2018-08-21

• Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels, 2019-11-29

• Secondary findings from clinical genomic sequencing: Prevalence, patient perspectives, family history assessment, and healthcare costs from a multi-site study, 2018-10-05

• The who, what and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study, 2017-10-26

• A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research, 2016-09-21

• Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium, 2013-10-24

• Genetic Complexity of Mitral Valve Prolapse Revealed by Clinical and Genetic Evaluation of a Large Family, 2019-06-19

• Examining the cascade of participant attrition in a genomic medicine research study: barriers and facilitators to achieving diversity, 2018-08-07

• The progression of the ClinGen gene clinical validity classification over time, 2018-08-08

• Germline Analysis from Tumor-Germline Sequencing Dyads to identify clinically actionable secondary findings, 2016-04-15

• Genomic Screening of the General Adult Population: Key Concepts for Assessing Net Benefit with Systematic Evidence Reviews, 2014-09-18

• Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid, 2016-06-21

• The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation, 2022-04-26

• Treatment-resistant psychotic symptoms and the 15q11.2 BP1-BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature, 2020-01-28

• Dnmt3a is essential for hematopoietic stem cell differentiation, 2011-12-04

• ReferencingBRCAin hereditary cancer risk discussions: In search of an anchor in a sea of uncertainty, 2020-01-22

• Exploring Concordance and Discordance for Return of Incidental Findings from Clinical Sequencing, 2012-03-15

• Development and Validation of a Genomic Knowledge Scale to Advance Informed Decision Making Research in Genomic Sequencing, 2017-02-01

• Expert and lay perspectives on burden, risk, tolerability, and acceptability of clinical interventions for genetic disorders, 2019-04-26

• ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing, 2013-06-20

• Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework, 2019-12-31

• A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories, 2016-11-03

• ACMG clinical laboratory standards for next-generation sequencing, 2013-07-25

• A semi-quantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing, 2015-08-13

• Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): Lessons Learned and Plans for the Future, 2018-09-05

• Towards robust clinical genome interpretation: developing a consistent terminology to characterize disease-gene relationships - allelic requirement, inheritance modes and disease mechanisms, 2023-04-03

• Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays, 2018-06-04

• Whole Exome Sequencing Identifies Truncating Variants in Nuclear Envelope Genes in Patients with Cardiovascular Disease, 2017-04-29

• A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation, 2016-04-28

• ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines, 2022-01-18

• Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing, 2017-01-12

• FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation, 2019-12-10

• Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial, 2021-04-29

• Parents' perceptions of personal utility of exome sequencing results, 2019-12-20

• Navigating the Research-Clinical Interface in Genomic Medicine: Analysis from the CSER Consortium, 2017-08-31